Ren Zhengrong, Shao Fang, Chen Shuli, Sun Yanyan, Ding Zhi, Dong Lei, Zhang Junfeng, Zang Yuhui
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, PR China.
J Pathol. 2025 May;266(1):95-108. doi: 10.1002/path.6414. Epub 2025 Mar 19.
Peritubular capillary (PTC) rarefaction is a common pathological feature of chronic kidney disease (CKD). The critical function of PTCs in maintaining blood supply for tubular epithelial cells renders PTCs a promising therapeutic target. However, the role of PTC rarefaction in the progression of kidney fibrosis remains elusive. In this study, we first characterized mice with altered PTC density. CD31 staining, together with microvascular network perfusion with FITC-labelled albumin and laser speckle contrast imaging, revealed a significant increase in PTC density in Flt1 heterozygous-deficient mice, whereas homozygous disruption of the plasminogen activator, urokinase receptor gene (Plaur/uPAR), led to a notable decrease in PTC density. Using these genetically distinct mice, we showed that preexisting higher PTC density protected against tubular injury and attenuated the progression of tubulointerstitial fibrosis in two distinct kidney injury models, namely, ischemia-reperfusion injury (IRI) and unilateral ureteral obstruction (UUO). By contrast, Plaur-deficient mice with established lower PTC density displayed exacerbated tubular injury and renal fibrosis when subjected to IRI or UUO. The pathophysiological significance of PTC density was associated with protective effects on tubular cell apoptosis and concomitant regeneration. Finally, vasodilation of the renal capillary with minoxidil, a clinically available drug, effectively prevented UUO-induced tubular injury and renal fibrosis. Moreover, minoxidil treatment abolished the detrimental effect of Plaur deficiency on the UUO-treated kidney, thus suggesting a causative role of PTC density in the susceptibility of Plaur knockout mice to tubular injury following fibrosis. Our results provide an overview of the pathologic significance of PTC density alterations in the progression of CKD, and show that improving peritubular microcirculation is effective in preventing tubular injury and the subsequent renal fibrosis. © 2025 The Pathological Society of Great Britain and Ireland.
肾小管周围毛细血管(PTC)稀疏是慢性肾脏病(CKD)常见的病理特征。PTC在维持肾小管上皮细胞血液供应方面的关键作用使其成为一个有前景的治疗靶点。然而,PTC稀疏在肾纤维化进展中的作用仍不清楚。在本研究中,我们首先对PTC密度改变的小鼠进行了特征描述。CD31染色,结合用异硫氰酸荧光素(FITC)标记白蛋白的微血管网络灌注和激光散斑对比成像,显示Flt1杂合缺陷小鼠的PTC密度显著增加,而纤溶酶原激活物、尿激酶受体基因(Plaur/uPAR)的纯合缺失导致PTC密度显著降低。利用这些基因不同的小鼠,我们发现在两种不同的肾损伤模型,即缺血再灌注损伤(IRI)和单侧输尿管梗阻(UUO)中,预先存在的较高PTC密度可保护肾小管免受损伤,并减轻肾小管间质纤维化的进展。相比之下,已建立较低PTC密度的Plaur缺陷小鼠在遭受IRI或UUO时,肾小管损伤和肾纤维化会加剧。PTC密度的病理生理意义与对肾小管细胞凋亡和伴随再生的保护作用有关。最后,用临床可用药物米诺地尔扩张肾毛细血管,有效预防了UUO诱导的肾小管损伤和肾纤维化。此外,米诺地尔治疗消除了Plaur缺陷对UUO处理肾脏的有害影响,从而提示PTC密度在Plaur基因敲除小鼠对纤维化后肾小管损伤易感性中的因果作用。我们的结果概述了PTC密度改变在CKD进展中的病理意义,并表明改善肾小管周围微循环可有效预防肾小管损伤及随后的肾纤维化。© 2025英国和爱尔兰病理学会